OOIR: Observatory of International Research

Papers

(The TQCC of Circulation-Cardiovascular Quality and Outcomes is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Race, Racism, and Cardiovascular Health: Applying a Social Determinants of Health Framework to Racial/Ethnic Disparities in Cardiovascular Disease	172
The Groundwater of Racial and Ethnic Disparities Research	75
2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to	74
Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care Patients	59
Comparative Efficacy of 5 Exercise Types on Cardiometabolic Health in Overweight and Obese Adults: A Systematic Review and Network Meta-Analysis of 81 Randomized Controlled Trials	52
Cardiovascular and Cerebrovascular Disease Mortality in Asian American Subgroups	50
Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global Collaboration	50
Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014–2018	49
Psychological Outcomes and Interventions for Individuals With Congenital Heart Disease: A Scientific Statement From the American Heart Association	49
Utilization and Availability of Advanced Imaging in Patients With Acute Ischemic Stroke	45
Characteristics and Outcomes of In-Hospital Cardiac Arrest Events During the COVID-19 Pandemic	45
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure	43
Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis	43
Harnessing Mobile Health Technology for Secondary Cardiovascular Disease Prevention in Older Adults: A Scientific Statement From the American Heart Association	42
Cardio-Renal-Metabolic Care Models	40
Digital Health Intervention in Acute Myocardial Infarction	39
Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: A Health Economic Analysis	39
Contemporary Trends in Hospital Admissions and Outcomes in Patients With Critical Limb Ischemia	38
External Validations of Cardiovascular Clinical Prediction Models: A Large-Scale Review of the Literature	38
Supervised Exercise Therapy for Symptomatic Peripheral Artery Disease Among Medicare Beneficiaries Between 2017 and 2018: Participation Rates and Outcomes	37
Million Hearts Cardiac Rehabilitation Think Tank: Accelerating New Care Models	36
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis	34
Working Agenda for Black Mothers	34
Preventing and Managing Falls in Adults With Cardiovascular Disease: A Scientific Statement From the American Heart Association	31
Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States	31

Performance Metrics for the Comparative Analysis of Clinical Risk Prediction Models Employing Machine Learning	30
Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012–2018	29
Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation	29
Impact of Produce Prescriptions on Diet, Food Security, and Cardiometabolic Health Outcomes: A Multisite Evaluation of 9 Produce Prescription Programs in the United States	28
Generalizability of Cardiovascular Disease Clinical Prediction Models: 158 Independent External Validations of 104 Unique Models	27
ABCs of Stroke Prevention	26
Variation in Out-of-Hospital Cardiac Arrest Survival Across Emergency Medical Service Agencies	26
Rural-Urban Differences in Mortality From Ischemic Heart Disease, Heart Failure, and Stroke in the United States	25
Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy	22
Socioeconomic Burden of Rising Methamphetamine-Associated Heart Failure Hospitalizations in California From 2008 to 2018	22
2021 Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19	22
Use of ACE (Angiotensin-Converting Enzyme) Inhibitors and Risk of Lung Cancer	22
Microrandomized Trial Design for Evaluating Just-in-Time Adaptive Interventions Through Mobile Health Technologies for Cardiovascular Disease	22
Ten-Year Trends in Patient Characteristics, Treatments, and Outcomes in Myocardial Infarction From National Cardiovascular Data Registry Chest Pain–MI Registry	22
Relationship of Preeclampsia With Maternal Place of Birth and Duration of Residence Among Non-Hispanic Black Women in the United States	21
Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study	20
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19	19
Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease	19
County-Level Social Vulnerability is Associated With In-Hospital Death and Major Adverse Cardiovascular Events in Patients Hospitalized With COVID-19: An Analysis of the American Heart Association COV	19
Role of Frailty in Identifying Benefit From Transcatheter Versus Surgical Aortic Valve Replacement	19
Determinants of Hospital Variation in Cardiac Rehabilitation Enrollment During Coronary Artery Disease Episodes of Care	19
Efficacy and Safety of Chinese Herbal Medicine Compared With Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial	19
Examining the Nocebo Effect of Statins Through Statin Adverse Events Reported in the Food and Drug Administration Adverse Event Reporting System	18
Severe Maternal Morbidity and Long-Term Risk of Cardiovascular Hospitalization	18
Integrated Care in Atrial Fibrillation	18
Palliative Care Across the Life Span for Children With Heart Disease: A Scientific Statement From the American Heart Association	18
Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes	18
Characteristics and Quality of National Cardiac Registries: A Systematic Review	18
Mendelian Randomization in Cardiovascular Research	17
Validity of International Classification of Diseases (ICD)-10 Diagnosis Codes for Identification of Acute Heart Failure Hospitalization and Heart Failure with Reduced Versus Preserved Ejection Fractio	17
Higher Emergency Physician Chest Pain Hospitalization Rates Do Not Lead to Improved Patient Outcomes	17
Cardiac Rehabilitation and the COVID-19 Pandemic: Persistent Declines in Cardiac Rehabilitation Participation and Access Among US Medicare Beneficiaries	17
Cardiovascular Disease Risk–Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network	17
Trends in Arterial Access Site Selection and Bleeding Outcomes Following Coronary Procedures, 2011–2018	17
Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration	16
2022 Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Car	16
Show Me the Money	16
Food Insecurity and Cardiovascular Mortality for Nonelderly Adults in the United States From 2011 to 2017	16
Cardiologist Evaluation of Patients With Type 2 Myocardial Infarction	16
Trends in Consumer Wearable Devices With Cardiac Sensors in a Primary Care Cohort	16
Relationship Between Social Determinants of Health and Antihypertensive Medication Adherence in a Medicaid Cohort	16
Text Message Medication Adherence Reminders Automated and Delivered at Scale Across Two Institutions: Testing the Nudge System: Pilot Study	16
2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Dat	16
Estimating the Effect of Reduced Attendance at Emergency Departments for Suspected Cardiac Conditions on Cardiac Mortality During the COVID-19 Pandemic	16
Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction	15
Neighborhoods and Cardiovascular Health: A Scientific Statement From the American Heart Association	14
Cardiovascular Disease Events and Mortality After Myocardial Infarction Among Black and White Adults	14
Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction	14
Strategies to Reduce Low-Value Cardiovascular Care: A Scientific Statement From the American Heart Association	14
Sources of Hospital Variation in Postacute Care Spending After Cardiac Surgery	14

Long-Term Prognosis of Patients With Coexisting Obesity and Malnutrition After Acute Myocardial Infarction: A Cohort Study	14
Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Dis	14
Practical Application of Patient-Reported Health Status Measures for Transcatheter Valve Therapies	14
Monotherapy Anticoagulation to Expedite Home Treatment of Patients Diagnosed With Venous Thromboembolism in the Emergency Department: A Pragmatic Effectiveness Trial	13
Cause of Death Among Patients With Peripheral Artery Disease	13
Association of Medicaid Expansion With Rates of Utilization of Cardiovascular Therapies Among Medicaid Beneficiaries Between 2011 and 2018	13
Joint Modeling of Longitudinal Markers and Time-to-Event Outcomes: An Application and Tutorial in Patients After Surgical Repair of Transposition of the Great Arteries	13
Best Practices for Education and Training of Resuscitation Teams for In-Hospital Cardiac Arrest	13
Lipid Testing, Lipid-Modifying Therapy, and PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Eligibility in 27 979 Patients With Incident Acute Coronary Syndrome	13
National Trends of Sex Disparity in the American College of Cardiology/American Heart Association Guideline Writing Committee Authors Over 15 Years	13
Toward Dynamic Risk Prediction of Outcomes After Coronary Artery Bypass Graft: Improving Risk Prediction With Intraoperative Events Using Gradient Boosting	13
Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry	13
Socioeconomic Status and Outcomes in Heart Failure With Reduced Ejection Fraction From Asia	13
Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis	12
2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Associati	12
Associations of Medicaid Expansion With Access to Care, Severity, and Outcomes for Acute Ischemic Stroke	12
Longer-Term Results of a Universal Electronic Consultation Program at the Cardiology Department of a Galician Healthcare Area	12
Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke	12
Perioperative Considerations for Pediatric Patients With Congenital Heart Disease Presenting for Noncardiac Procedures: A Scientific Statement From the American Heart Association	12
Estimation of the Absolute Risk of Cardiovascular Disease and Other Events: Issues With the Use of Multiple Fine-Gray Subdistribution Hazard Models	12
Risk Stratification of Patients Undergoing Percutaneous Repair of Mitral and Tricuspid Valves Using a Multidimensional Geriatric Assessment	12
Association Between Early Trauma and Ideal Cardiovascular Health Among Black Americans	12
Benefits and Harms of Hypertension and High-Normal Labels: A Randomized Experiment	11
Trends of Coronary Artery Bypass Grafting Performance in a Cohort of Hospitals in China Between 2013 and 2018	11
Changes in Home Blood Pressure Monitored Among Elderly Patients With Hypertension During the COVID-19 Outbreak: A Longitudinal Study in China Leveraging a Smartphone-Based Application	11
In-Hospital Cardiac Arrest Survival in the United States During and After the Initial Novel Coronavirus Disease 2019 Pandemic Surge	11
Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER	11
Provider Care Team Segregation and Operative Mortality Following Coronary Artery Bypass Grafting	11
Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States	11
Exposure to Neighborhood-Level Racial Residential Segregation in Young Adulthood to Midlife and Incident Subclinical Atherosclerosis in Black Adults: The Coronary Artery Risk Development in Young Adul	10
Contributions of Structural Racism to the Food Environment: A Photovoice Study of Black Residents With Hypertension in Baltimore, MD	10
Efforts to Improve Survival Outcomes of Out-of-Hospital Cardiac Arrest in China: BASIC-OHCA	10
Prior Authorization, Copayments, and Utilization of Sacubitril/Valsartan in Medicare and Commercial Plans in Patients With Heart Failure With Reduced Ejection Fraction	10
Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended In	10
Examining Neighborhood Socioeconomic Status as a Mediator of Racial/Ethnic Disparities in Hypertension Control Across Two San Francisco Health Systems	10
Progression of Preclinical Heart Failure: A Description of Stage A and B Heart Failure in a Community Population	10
Ten Steps Toward Improving In-Hospital Cardiac Arrest Quality of Care and Outcomes	9
Validation of Cardiovascular End Points Ascertainment Leveraging Multisource Electronic Health Records Harmonized Into a Common Data Model in the ADAPTABLE Randomized Clinical Trial	9
Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019	9
Social Determinants of Adherence to COVID-19 Risk Mitigation Measures Among Adults With Cardiovascular Disease	9
Trajectories of Pain After Cardiac Surgery: Implications for Measurement, Reporting, and Individualized Treatment	9
Reimagining Evidence Generation for Heart Failure and the Role of Integrated Health Care Systems	9
Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia: A Quality Improvement Study	9
Hospital and Operator Variation in Cardiac Rehabilitation Referral and Participation After Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Consortiu	9
Target: Stroke Was Associated With Faster Intravenous Thrombolysis and Improved One-Year Outcomes for Acute Ischemic Stroke in Medicare Beneficiaries	9
Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322 153 Patients	9
Comparison of Investigator-Reported and Clinical Event Committee–Adjudicated Outcome Events in GLASSY	9
Practice Patterns and Outcomes Associated With Anticoagulation Use Following Sepsis Hospitalizations With New-Onset Atrial Fibrillation	9
Use of Artificial Intelligence Tools Across Different Clinical Settings	9
Response by Chan to Letter Regarding Article, “In-Hospital Cardiac Arrest Survival in the United States During and After the Initial Novel Coronavirus Disease 2019 Pandemic Surge”	8
Competitive Sports, the Coronavirus Disease 2019 Pandemic, and Big Ten Athletics	8
Personalized, Electronic Health Record–Integrated Decision Aid for Stroke Prevention in Atrial Fibrillation: A Small Cluster Randomized Trial and Qualitative Analysis of Efficacy and Acceptability	8
Rationale and Design of the SAFE-PAD Study	8
Early Increased Physical Activity, Cardiac Rehabilitation, and Survival After Implantable Cardioverter-Defibrillator Implantation	8
Generalizability of DAPA-CKD to the United States	8
Integrating Community Health Workers into Community-Based Primary Care Practice Settings to Improve Blood Pressure Control Among South Asian Immigrants in New York City: Results from a Randomized Cont	8
Examination of Sexual Identity Differences in the Prevalence of Hypertension and Antihypertensive Medication Use Among US Adults: Findings From the Behavioral Risk Factor Surveillance System	8
Quantifying Blood Pressure Visit-to-Visit Variability in the Real-World Setting: A Retrospective Cohort Study	7
Variation in Cardiac Rehabilitation Participation During Aortic Valve Replacement Episodes of Care	7
American Heart Association Precision Medicine Platform Addresses Challenges in Data Sharing	7
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative	7
Cardiovascular Risk Assessment Using Artificial Intelligence-Enabled Event Adjudication and Hematologic Predictors	7
Systemizing the Evaluation of Acute Heart Failure in the Emergency Department	7
Coronary Artery Bypass Surgery in Patients With COVID-19	7
Artificial Intelligence–Enabled Model for Early Detection of Left Ventricular Hypertrophy and Mortality Prediction in Young to Middle-Aged Adults	7
Association of State Medicaid Expansion Status With Hypertensive Disorders of Pregnancy in a Singleton First Live Birth	7
Nationwide Implementation of a Population Management Dashboard for Monitoring Direct Oral Anticoagulants: Insights From the Veterans Affairs Health System	7
Improving Outcome Predictions for Patients Receiving Mechanical Circulatory Support by Optimizing Imputation of Missing Values	7
Increasing Uptake of Depression Screening and Treatment Guidelines in Cardiac Patients: A Behavioral and Implementation Science Approach to Developing a Theory-Informed, Multilevel Implementation Stra	7
Interim Guidance for Emergency Medical Services Management of Out-of-Hospital Cardiac Arrest During the COVID-19 Pandemic	7
The Cardiovascular Quality Improvement and Care Innovation Consortium	7
Contemporary Rates of Hospitalization for Heart Failure in Young and Middle-Aged Adults in a Diverse US State	7
Relation of Household Income to Access and Adherence to Combination Sacubitril/Valsartan in Heart Failure: A Retrospective Analysis of Commercially Insured Patients	7
Estimating Long-Term Health Utility Scores and Expenditures for Cardiovascular Disease From the Medical Expenditure Panel Survey	7
Incidence of Timely Outpatient Follow-Up Care After Emergency Department Encounters for Acute Heart Failure	7
Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF–TIMI 48 Trial	7
One-Year Outcomes and Factors Associated With Mortality Following Acute Myocardial Infarction in Northern Tanzania	7
Establishing Thresholds for Minimal Clinically Important Differences for the Peripheral Artery Disease Questionnaire	7
Association of Cardiac Care Regionalization With Access, Treatment, and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction	7
Influence of Hospital Characteristics on Hospital Transfer Destinations for Patients With Stroke	7

Financial Toxicity With Cardiovascular Disease Management	6
Safer Stroke-Dx Instrument: Identifying Stroke Misdiagnosis in the Emergency Department	6
Why Is Intravascular Ultrasound Guidance Underutilized in Percutaneous Coronary Intervention?: It Is Not “All About the Benjamins”	6
Evidence-Based Policy Making for Public Health Interventions in Cardiovascular Diseases: Formally Assessing the Feasibility of Clinical Trials	6
Understanding Baseline Physical Activity in Cardiac Rehabilitation Enrollees Using Mobile Health Technologies	6
Association Between Electrocardiographic Age and Cardiovascular Events in Community Settings: The Framingham Heart Study	6
Urban Spatial Accessibility of Primary Care and Hypertension Control and Awareness on Chicago’s South Side: A Study From the COMPASS Cohort	6
Leveraging Remote Physiologic Monitoring in the COVID-19 Pandemic to Improve Care After Cardiovascular Hospitalizations	6
Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin Among Adults With Cancer and Atrial Fibrillation	6
2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force	6
Trends of Concomitant Diabetes and Peripheral Artery Disease and Lower Extremity Amputation in US Medicare Patients, 2007 to 2019	6
Optimal Methods for Reducing Proxy-Introduced Bias on Patient-Reported Outcome Measurements for Group-Level Analyses	6
Mapping Geographic Proximity to Cardiologists Across the United States	6
Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association/American College of	6
Early Stage and Established Hypertension in Sub-Saharan Africa: Results From Population Health Surveys in 17 Countries, 2010–2017	6
Target Aortic Stenosis: A National Initiative to Improve Quality of Care and Outcomes for Patients With Aortic Stenosis	6
Thirty-Day and 90-Day Episode of Care Spending Following Heart Failure Hospitalization Among Medicare Beneficiaries	6
Statin Prescribing Patterns During In-Person and Telemedicine Visits Before and During the COVID-19 Pandemic	6
Validation of the International Classification of Diseases, Tenth Revision Code for the National Institutes of Health Stroke Scale Score	6
Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department	6
Accuracy of Cardiovascular Trial Outcome Ascertainment and Treatment Effect Estimates from Routine Health Data: A Systematic Review and Meta-Analysis	6
Social Determinants of Cardiovascular Health in an Era of Rising Social Disadvantage	6
Early Termination of Acute Stroke Randomized Controlled Trials Published Between 2013 and 2020: A Systematic Review	6
Approval, Evidence, and “Off-Label” Device Utilization: The Patent Foramen Ovale Closure Story	6
Association of Clinical Setting With Sociodemographics and Outcomes Following Endovascular Femoropopliteal Artery Revascularization in the United States	6
Cost Effectiveness of Interhospital Transfer for Mechanical Thrombectomy of Acute Large Vessel Occlusion Stroke	6
Sociodemographic Disparities in Outpatient Cardiology Telemedicine During the COVID-19 Pandemic	6
Evidence-Based Process Performance Measures and Clinical Outcomes in Patients With Incident Heart Failure With Reduced Ejection Fraction: A Danish Nationwide Cohort Study	6
Changes in Emergency Department Arrival Times for Acute Myocardial Infarction During the COVID-19 Pandemic Suggest Delays in Care Seeking	6
Addressing Gaps in Racial/Ethnic Representation in Familial Hypercholesterolemia Registries	6